No CrossRef data available.
Published online by Cambridge University Press: 02 July 2020
Poly-(trans-l,2-diaminocyclohexane) platinumj-carboxyamylose (Poly-Plat); 5-SuIfosalicylato-trans-(l,2-diaminocyclohexane) platinum (SSP); and 4-Hydroxy-a-sulfonylphenylacetato (trans 1,2-diaminocyclohexane) platinum (II) (SAP) (Andrulis Pharmaceuticals, Bethesda, MD) are three novel second generation platinum containing antineoplastic compounds. Initial studies indicate that these agents are more effective in the treatment of cancer while at the same time less toxic to the organism as a whole than cisplatin (CDDP). The present study was undertaken to examine the effects of these new compounds on glucose-6-phosphate dehydrogenase (G-6-PDH) as compared to CDDP treated and normal kidney and liver tissues.
Wistar rats (100-120g) were given intraperitoneal injections of CDDP (9 mg/ kg) and Poly-Plat, SSP and SAP (10 mg/ kg) over a 5 day period. On day 6 the animals were sacrificed and tissues (kidney and liver) were freeze sectioned (7 μm). Sections were incubated in media according to the accepted method specific for the G-6-PDH localization at a pH of 7.46 for 30 min.
1. Bogin, E., et al.Eur J Clin Chem Clin Biochem. 32 (1994) 843–851.Google Scholar
2. Lubert, Stryer. Biochemistry. 4th ed. New York: W.H. Freeman and Company, p. 568. 1995.Google Scholar
3. Cafruny, E., et al.J Pharmacol Exp Ther. 115 (1955) 390–401.Google Scholar
4. Meara, , et al. J Histochem Cytochem, (1997) submitted.Google Scholar